Vimarsana
Biggest News Aggregation in the World

Page 18 - Jon Patton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jon Patton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jon Patton Today - Breaking & Trending Today

Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting - Vimarsana News

Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting

Published: March 9, 2022

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced an upcoming poster presentation that will feature long-term follow-up...

Source: prnewswire.com
Related Topics:
United StatesJon PattonTimothy MccarthyOncolytics Biotech IncAmerican Association For Cancer ResearchCompany ContactOncolytics BiotechSecurities ExchangeErnestn Morial Convention CenterAmerican AssociationCancer ResearchAnnual MeetingConvention CenterNew OrleansPhasei Clinical TrialsSecurities Exchange ActOncolytics Biotech IncBiotechnology Health Care Amp Hospitals New Products Amp Services
Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting - Vimarsana News

Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting

Published: March 9, 2022

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced phase 1b data demonstrating clinical proof-of-concept for...

Source: prnewswire.com
Related Topics:
New OrleansUnited StatesNew Orleans Convention CenterKevin KellyJon PattonTimothy MccarthyThomas HeinemanOncolytics Biotech IncUnited States National Cancer InstituteCompany ContactErnestn Morial Convention CenterOrleans Convention CenterAmerican Association For Cancer ResearchOncolytics BiotechSecurities ExchangeBristol Myers SquibbAmerican AssociationCancer ResearchAnnual MeetingConvention CenterAssociate ProfessorClinical MedicineKeck SchoolSouthern CaliforniaPrincipal Investigator
Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting - Vimarsana News

Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting

Published: March 9, 2022

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced phase 1b data demonstrating clinical proof-of-concept for...

Source: prnewswire.com
Related Topics:
New OrleansUnited StatesNew Orleans Convention CenterKevin KellyJon PattonTimothy MccarthyThomas HeinemanOncolytics Biotech IncUnited States National Cancer InstituteCompany ContactErnestn Morial Convention CenterOrleans Convention CenterAmerican Association For Cancer ResearchOncolytics BiotechSecurities ExchangeBristol Myers SquibbAmerican AssociationCancer ResearchAnnual MeetingConvention CenterAssociate ProfessorClinical MedicineKeck SchoolSouthern CaliforniaPrincipal Investigator
Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting - Vimarsana News

Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting

Published: March 9, 2022

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced an upcoming poster presentation that will feature long-term follow-up...

Source: prnewswire.com
Related Topics:
United StatesJon PattonTimothy MccarthyOncolytics Biotech IncAmerican Association For Cancer ResearchCompany ContactOncolytics BiotechSecurities ExchangeErnestn Morial Convention CenterAmerican AssociationCancer ResearchAnnual MeetingConvention CenterNew OrleansPhasei Clinical TrialsSecurities Exchange ActOncolytics Biotech Inc
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights - Vimarsana News

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights

Published: March 3, 2022

Randomized phase 2 metastatic breast cancer trial (BRACELET-1) on track for top-line data in Q4 2022 Clinical breast cancer data indicate pelareorep-induced...

Source: prnewswire.com
Related Topics:
United StatesSan AntonioMatt CoffeyThomasc HeinemanJon PattonTimothy MccarthyGenocea BiosciencesAdlai NortyeOncolytics Biotech IncHead Of Clinical Development At Denovo BiopharmaCompany ContactGlobal Clinical ResearchGastrointestinal Cancers ProgramOncolytic Global Head Of Clinical DevelopmentHead Of Clinical DevelopmentOncolytics BiotechBreast Cancer ProgramSaint Louis University School Of MedicineSecurities ExchangeChief Executive OfficerAntonio Breast CancerNorth AmericanAmerican SocietyData Safety Monitoring BoardChief Medical